Strategic CMC & Regulatory Expertise
Xseer Pharmaceuticals provides comprehensive Chemistry, Manufacturing, and Controls (CMC) expertise designed to bridge the gap between scientific development and regulatory approval. Functioning as a strategic extension of your internal team, we navigate the complex interdependencies between drug substance characterization, process engineering, and phase-appropriate quality controls. From early IND-enabling studies through late-phase clinical supply and commercialization, our regulatory and technical teams deliver data-driven CMC strategies that mitigate risk, accelerate submission timelines, and ensure alignment with FDA, ICH, and cGMP standards.
Core CMC Capabilities
- Strategic CMC Planning & Lifecycle Management
Navigating regulatory expectations requires a proactive, phase-appropriate strategy. We design and execute comprehensive CMC roadmaps tailored to your molecule's specific development stage, ensuring that formulation, analytical, manufacturing, and control strategies evolve appropriately throughout development without triggering regulatory delays or clinical holds. - Technology Transfer & Process Validation
A successful transition from the laboratory bench to the commercial manufacturing floor is critical for supply continuity. Our CMC engineers oversee rigorous technology transfer protocols, process scale-up, process validation, and ongoing process monitoring to ensure reproducible, cGMP-compliant manufacturing at every clinical and commercial scale. - Regulatory Documentation & Submission Support
We transform complex analytical and manufacturing data into audit-ready regulatory documentation. Our regulatory experts provide extensive support for the assembly, technical authoring, gap assessment, and review of CMC modules (eCTD Module 3) for IND, NDA, ANDA, and BLA submissions, ensuring your data package withstands the rigorous scrutiny of regulatory agencies. - Quality Risk Management (QRM) & QbD
Embracing Quality by Design (QbD) principles, we proactively identify and mitigate technical vulnerabilities early in the product lifecycle. Through comprehensive risk assessments, critical process parameter (CPP) mapping, and the establishment of robust control strategies, we safeguard product quality and streamline the path to market. - Post-Approval Change Management & Lifecycle Support
Regulatory approval is not the end of the CMC journey. Xseer supports ongoing lifecycle management activities including manufacturing changes, specification updates, analytical method modifications, technology transfers, and regulatory impact assessments. Our team helps sponsors maintain compliance while implementing continuous improvement initiatives throughout the commercial product lifecycle.
Our Commitment to Partnership
By harmonizing formulation science, manufacturing operations, and analytical controls under a unified regulatory strategy, Xseer empowers biotech innovators and pharmaceutical sponsors to navigate the complex regulatory landscape with confidence, transparency, and continuous compliance.
